Summary
Unable to evaluate alignment: only a boxed cardiovascular risk excerpt was provided, while the AI response contains many specific indication, dosing/administration, contraindication- and interaction-assertions, adverse effects, and missed-dose/overdose instructions that are not supported or contradicted by the provided label text.
Category Scores
Accurate Statements
Indomethacin is a prescription nonsteroidal anti-inflammatory drug (NSAID).
Not verifiable from the provided label excerpt (only boxed cardiovascular risk excerpt was provided).
Unsupported Statements
A 25 mg indomethacin capsule is used to reduce pain, inflammation, and swelling from inflammatory arthritis.
No indication/product-specific dosing information provided in the supplied label excerpts.
A 25 mg indomethacin capsule is used to reduce pain, inflammation, and swelling from other musculoskeletal inflammatory problems.
No indication/product-specific dosing information provided in the supplied label excerpts.
Indomethacin is available in multiple formulations, including capsules and extended-release products in some markets.
No formulation/strength/product-availability details provided in the supplied label excerpts.
A 25 mg capsule is intended for regular dosing schedules.
No dosing schedule details provided in the supplied label excerpts.
Extended-release versions of indomethacin are designed to last longer.
No extended-release pharmacokinetic/label wording provided in the supplied label excerpts.
Extended-release versions of indomethacin can reduce dosing frequency.
No dosing-frequency guidance provided in the supplied label excerpts.
A 25 mg indomethacin capsule should be taken exactly as directed by a clinician.
No administration instructions provided in the supplied label excerpts.
NSAID capsules are commonly taken with food or milk to reduce stomach irritation.
No administration-with-food guidance provided in the supplied label excerpts.
The lowest effective dose should be used for the shortest needed time with NSAIDs.
No general NSAID dosing-duration instruction provided in the supplied label excerpts.
One should not exceed the prescribed daily dose of indomethacin.
No dosing limit/max daily dose language provided in the supplied label excerpts.
Common adverse effects of indomethacin and other NSAIDs include stomach upset.
No adverse reaction list/excerpt provided in the supplied label excerpts.
Common adverse effects of indomethacin and other NSAIDs include heartburn.
No adverse reaction list/excerpt provided in the supplied label excerpts.
Common adverse effects of indomethacin and other NSAIDs include nausea.
No adverse reaction list/excerpt provided in the supplied label excerpts.
Indomethacin and other NSAIDs increase the risk of stomach irritation or bleeding.
No GI risk warning excerpt provided in the supplied label excerpts.
Gastrointestinal bleeding symptoms of indomethacin include black stools or bloody stools or vomiting blood.
No GI bleeding symptom guidance provided in the supplied label excerpts.
Clinicians often take extra precautions or avoid NSAIDs in people with a history of stomach ulcers or GI bleeding.
No contraindication/warning eligibility criteria provided in the supplied label excerpts.
Clinicians often take extra precautions or avoid NSAIDs in people with significant kidney disease.
No renal warning/contraindication criteria provided in the supplied label excerpts.
Clinicians often take extra precautions or avoid NSAIDs in people with certain heart or blood vessel diseases or high cardiovascular risk.
No label text provided for cardiovascular risk beyond the boxed cardiovascular risk heading/excerpt; specific population guidance not provided.
Clinicians often take extra precautions or avoid NSAIDs in people with NSAID allergy or NSAID-triggered asthma or swelling.
No hypersensitivity/NSAID-triggered asthma guidance provided in the supplied label excerpts.
Clinicians often take extra precautions or avoid NSAIDs in people using blood thinners or other medications that raise bleeding risk.
No anticoagulant/bleeding-risk interaction warnings provided in the supplied label excerpts.
Indomethacin can interact with medicines that affect bleeding risk.
No interaction information provided in the supplied label excerpts.
Indomethacin can interact with medicines that affect kidney function.
No interaction information provided in the supplied label excerpts.
Examples of interacting drugs with indomethacin include anticoagulants (blood thinners).
No interaction examples provided in the supplied label excerpts.
Examples of interacting drugs with indomethacin include antiplatelet drugs.
No interaction examples provided in the supplied label excerpts.
Examples of interacting drugs with indomethacin include other NSAIDs.
No interaction examples provided in the supplied label excerpts.
Indomethacin can interact with some blood pressure or diuretic regimens.
No interaction information provided in the supplied label excerpts.
If a dose of indomethacin is missed, it should be taken when remembered unless it is close to the next dose.
No missed-dose instructions provided in the supplied label excerpts.
If a dose of indomethacin is missed, the dose should not be doubled up.
No missed-dose instructions provided in the supplied label excerpts.
If more than the prescribed indomethacin dose is taken, one should contact a clinician or poison control for guidance.
No overdose/poison control guidance provided in the supplied label excerpts.
NSAID overdoses can be dangerous.
No overdose safety statement provided in the supplied label excerpts.
Indomethacin is widely available as a generic.
No availability/market status statements provided in the supplied label excerpts.
Contradictions
Important Omissions
The AI response contains numerous clinically relevant claims (indications, dosing, GI/renal/cardiovascular cautions, contraindications/hypersensitivity, drug–drug interactions, adverse reactions, missed-dose and overdose instructions), but the provided FDA label excerpts include only a boxed cardiovascular risk snippet and do not include the corresponding label sections needed to verify support/contradiction.
Importance:
High
Safety Assessment
Potential Patient Risk:
High
Because most AI claims cannot be verified against the supplied label excerpts, there is a high risk of inaccuracies, especially regarding dosing/administration, interactions, and safety warnings that are not present in the provided label text.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Assessable
Primary Issue
Insufficient FDA label content provided (only a boxed cardiovascular risk excerpt), preventing verification of most drug-label-alignment claims made by the AI response.
Suggested Improvement
Provide the full FDA-approved prescribing information sections for indomethacin capsules (indications and usage, dosage and administration, contraindications, warnings/precautions, drug interactions, adverse reactions, and any missed-dose/overdose guidance) so each AI statement can be assessed for support or contradiction.